Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (261-270 of 331) with videos related to

Pageof 34
Sort By:
Annals of Internal Medicine|June 30, 2025
Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysisBryce Montané, Shiyang Zhang, Jonathan D Wolfe, et al.
JAMA|August 23, 2017
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialG Michael Felker, Kevin J Anstrom, Kirkwood F Adams, et al.
JAMA Cardiology|March 30, 2017
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical TrialPatricia A Cowper, Shubin Sheng, Renato D Lopes, et al.
Circulation. Cardiovascular Quality and Outcomes|February 3, 2025
Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized TrialDaniel B Mark, Yanhong Li, Michael G Nanna, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2024
Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trialSripal Bangalore, Grace Rhodes, David J Maron, et al.
JACC. Advances|August 12, 2024
Combinations of First Responder and Drone Delivery to Achieve 5-Minute AED Deployment in OHCAMonique A Starks, Jamal Chu, K H Benjamin Leung, et al.
Annals of Internal Medicine|September 16, 2014
Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trialDaniel B Mark, J David Knight, Eric J Velazquez, et al.
JACC. Heart Failure|July 16, 2014
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure)Ralph A H Stewart, Dominika Szalewska, Lilin She, et al.
JACC. Heart Failure|September 8, 2014
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart FailureG Michael Felker, Tariq Ahmad, Kevin J Anstrom, et al.
Journal of the American Geriatrics Society|February 16, 2026
The Importance of Age in Selecting a Testing Strategy for Stable Symptomatic Patients With Suspected Coronary Artery DiseaseEvangelia Vemmou, Michelle D Kelsey, Sreekanth Vemulapalli, et al.
Pageof 34

Showing results (261-270 of 331) with videos related to

Sort By:
Pageof 34
Annals of Internal Medicine|June 30, 2025
Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysisBryce Montané, Shiyang Zhang, Jonathan D Wolfe, et al.
JAMA|August 23, 2017
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialG Michael Felker, Kevin J Anstrom, Kirkwood F Adams, et al.
JAMA Cardiology|March 30, 2017
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical TrialPatricia A Cowper, Shubin Sheng, Renato D Lopes, et al.
Circulation. Cardiovascular Quality and Outcomes|February 3, 2025
Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized TrialDaniel B Mark, Yanhong Li, Michael G Nanna, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2024
Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trialSripal Bangalore, Grace Rhodes, David J Maron, et al.
JACC. Advances|August 12, 2024
Combinations of First Responder and Drone Delivery to Achieve 5-Minute AED Deployment in OHCAMonique A Starks, Jamal Chu, K H Benjamin Leung, et al.
Annals of Internal Medicine|September 16, 2014
Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trialDaniel B Mark, J David Knight, Eric J Velazquez, et al.
JACC. Heart Failure|July 16, 2014
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure)Ralph A H Stewart, Dominika Szalewska, Lilin She, et al.
JACC. Heart Failure|September 8, 2014
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart FailureG Michael Felker, Tariq Ahmad, Kevin J Anstrom, et al.
Journal of the American Geriatrics Society|February 16, 2026
The Importance of Age in Selecting a Testing Strategy for Stable Symptomatic Patients With Suspected Coronary Artery DiseaseEvangelia Vemmou, Michelle D Kelsey, Sreekanth Vemulapalli, et al.
Pageof 34